Frank Milton Balis

8PUBLICATIONS
57CO-AUTHORS
Molecular targetsPharmacogenomicsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

|Feb 11, 2025
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis.

Frank M Balis, Elizabeth Rieger, Nancy J Bunin

|Jun 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane

|Sep 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.

Purnima Singh, Disheet A Shah, Mariam Jouni

|Oct 16, 2019
The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma.

Frank Milton Balis, Christine Maria Busch, Ami Vijay Desai

|Feb 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.

Peter C Adamson, Gareth J Veal, Richard B Womer

Pageof 2

Frequent Collaborators

2 joint publications

Smita Bhatia

1 joint publications

Suzanne P MacFarland

1 joint publications

Lea F Surrey

1 joint publications

Jennifer M Kalish